Ahmed, Ali

Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial

Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., Love, T. E., Aronow, W. S., Adams, K. F., & Gheorghiade, M. (2006) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 605

Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Serban, M., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., Andrica, F., Ahmed, A., Aronow, W. S., Muntner, P., et al. (2016) · Journal of the American Heart Association

Phytochemicals and Antioxidant ActivitiesBlood Pressure and Hypertension Studies

Cited by 317

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

Gheorghiade, M., Fonarow, G. C., van Veldhuisen, D. J., Cleland, J. G. F., Butler, J., Epstein, A. E., Patel, K., Aban, I. B., Aronow, W. S., Anker, S. D., et al. (2013) · European Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 192

Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension

Smith, S. M., Gong, Y., Handberg, E., Messerli, F. H., Bakris, G. L., Ahmed, A., Bavry, A. A., Pepine, C. J., & Cooper-DeHoff, R. M. (2014) · Journal of Hypertension

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 115

Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial

Bowling, C. B., Sanders, P. W., Allman, R. M., Rogers, W. J., Patel, K., Aban, I. B., Rich, M. W., Pitt, B., White, M., Bakris, G. C., et al. (2013) · International Journal of Cardiology

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 85

Digoxin discontinuation and outcomes in patients with heart failure with reduced ejection fraction

Malik, A., Masson, R., Singh, S., Wu, W.-C., Packer, M., Pitt, B., Waagstein, F., Morgan, C. J., Allman, R. M., Fonarow, G. C., et al. (2019) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 55

Renin-angiotensin system inhibition and lower 30-day all-cause readmission in Medicare beneficiaries with heart failure

Sanam, K., Bhatia, V., Bajaj, N. S., Gaba, S., Morgan, C. J., Fonarow, G. C., Butler, J., Deedwania, P., Prabhu, S. D., Wu, W.-C., et al. (2016) · The American Journal of Medicine

Heart Failure Treatment and ManagementRenin-Angiotensin System Studies

Cited by 50

Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate

Lam, P. H., Gupta, N., Dooley, D. J., Singh, S., Deedwania, P., Zile, M. R., Bhatt, D. L., Morgan, C. J., Pitt, B., Fonarow, G. C., et al. (2018) · The American Journal of Medicine

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 36

Incident Atrial Fibrillation and Mortality in Older Adults with Heart Failure

Ahmed, A., & Perry, G. J. (2005) · European Journal of Heart Failure

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 35

Exercise blood pressure, cardiorespiratory fitness and mortality risk

Kokkinos, P., Faselis, C., Sidossis, L., Zhang, J., Samuel, I. B. H., Ahmed, A., Karasik, P., Pittaras, A., Doumas, M., Grassos, C., et al. (2021) · Progress in Cardiovascular Diseases

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 16